Clinical Trials

79 enrolled

Uterine Cervical Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT04065269 2026-02-20

ATARI

174 enrolled

GynecologicSarcoma

Carcinosarcoma, Uterine Cervical Neoplasms, Endometrial Neoplasms, Carcinoma, Endometrioid

NCT04258813 2026-02-20

ONE TEAM

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

313 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Cardiovascular Diseases, Colonic Neoplasms, Diabetes Mellitus, Esophageal Neoplasms, Head and Neck Neoplasms, Hypercholesterolemia, Hypertension, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT04251416 2026-02-17

A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma

50 enrolled

Endometrial Neoplasms

NCT04930159 2026-02-17

SISTER

252 enrolled

Endometrial Neoplasms

NCT03008408 2026-02-11

A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma

90 enrolled

Endometrial Neoplasms

NCT04781088 2026-02-11

Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

38 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT05761951 2026-02-11

Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer

8 enrolled

Endometrial Neoplasms

NCT03932409 2026-02-10

FIERCE

45 enrolled

Endometrial Neoplasms

NCT03120624 2026-02-04

VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer

34 enrolled 16 charts

Endometrial Neoplasms

NCT06483997 2026-01-29

Diet, Hepcidin, and Chemotherapy RDI

Classical hematologyGynecologic

100 enrolled

Anemia, Fallopian Tube Neoplasms, Inflammation, Ovarian Neoplasms, Endometrial Neoplasms

NCT02658565 2026-01-22

Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation

401 enrolled

Endometrial Neoplasms

NCT04576104 2026-01-21

Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer

51 enrolled

Endometrial Hyperplasia, Endometrial Neoplasms

NCT06129604 2026-01-15

Pilot Window of Opportunity Trial (POET)

GastrointestinalGynecologic

10 enrolled

Colorectal Neoplasms, Endometrial Neoplasms

NCT03671811 2026-01-06

Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy

44 enrolled 12 charts

Endometrial Hyperplasia, Endometrial Neoplasms

NCT03955978 2026-01-06

TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer

10 enrolled

Endometrial Neoplasms

NCT02285192 2025-12-30

Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer

42 enrolled

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT05220033 2025-12-30

Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer

30 enrolled

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT05407025 2025-12-19

Targeting Inflammation for Endometrial Cancer Prevention

191 enrolled

Endometrial Neoplasms

NCT07283029 2025-12-15

Activity and Cancer Survivorship Exercise Pilot

10 enrolled

Phase 3 Active not recruiting

Endometrial Neoplasms

NCT05201547 2025-12-04

DOMENICA

260 enrolled

Neoplasm Metastasis, Endometrial Neoplasms

NCT01068249 2025-11-18

Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer

42 enrolled 11 charts

Recurrence, Endometrial Neoplasms

NCT04634617 2025-11-10

Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors

310 enrolled

Uterine Neoplasms, Endometrial Neoplasms

NCT01797523 2025-11-06

A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma

62 enrolled

Endometrial Neoplasms

NCT03526432 2025-10-24

Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer

110 enrolled

Endometrial Neoplasms

NCT04763915 2025-09-19

IMPACT

BreastGastrointestinalGenitourinaryGynecologic

720 enrolled

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT03285152 2025-09-03

A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients

19 enrolled

Endometrial Neoplasms

NCT04569773 2025-08-22

Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer

43 enrolled

Endometrial Neoplasms

NCT00514254 2025-08-12

Risk Factors for Endometrial Cancer in Black Women

59 enrolled

Endometrial Neoplasms

NCT03776630 2025-08-12

GYNO-MIR

363 enrolled

Phase 1/2 Active not recruiting

Disease, Ovarian Neoplasms, Endometrial Neoplasms

NCT05057013 2025-08-11

A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

81 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Lethal Congenital Contracture Syndrome 2, Fibromatosis, Gingival, 2, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Prostatic Neoplasms, Castration-Resistant, Triple Negative Breast Neoplasms

NCT02912572 2025-07-10

Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer

106 enrolled 16 charts

Endometrial Neoplasms

NCT04000880 2025-06-12

AMPLIFY

BreastGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidPlasma cell

603 enrolled

Breast Neoplasms, Kidney Neoplasms, Lymphoma, Non-Hodgkin, Motor Activity, Multiple Myeloma, Ovarian Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT03835819 2025-05-15

A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)

18 enrolled 17 charts

Endometrial Neoplasms

NCT06963385 2025-05-09

ROME

250 enrolled

Uterine Neoplasms, Endometrial Neoplasms

NCT04713618 2025-03-18

Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy

GastrointestinalGynecologic

89 enrolled

Anus Neoplasms, Uterine Cervical Neoplasms, Pelvic Neoplasms, Rectal Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT06014580 2025-03-07

MADONNA

276 enrolled

Endometrial Neoplasms

NCT05591131 2025-02-21

GTM-I

21 enrolled

Ovarian Neoplasms, Endometrial Neoplasms

NCT06800677 2025-01-30

BioMEC

200 enrolled

Endometrial Neoplasms

NCT04719273 2025-01-08

Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer

14 enrolled

Endometrial Neoplasms

NCT05682950 2024-11-21

Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer

15 enrolled

Phase 1/2 Active not recruiting

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT05869123 2024-11-21

Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer

17 enrolled

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT05139368 2024-11-18

RT-PACE

22 enrolled

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06584630 2024-09-19

Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.

80 enrolled